Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerNPI Medicare & MedicaidRoneka Ravenell
    Ask Trek AI about this page

    Roneka Ravenell — Billing Profile & Reimbursement Data

    NPI 1972682334 · New Albany, IN · Rheumatology Physician

    Customize your policy alerts

    Sign up for Roneka Ravenell — Billing Profile & Reimbursement Data policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Roneka Ravenell is a rheumatology physician provider located in New Albany, Indiana. This profile covers 29 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Provider details (source: NPPES NPI Registry)

    FieldValue
    Entity TypeIndividual
    OrganizationRoneka Ravenell
    Address3897 Charlestown Rd
    CityNew Albany
    StateIN
    ZIP47150
    TaxonomyRheumatology Physician
    NPI EnumeratedNovember 4, 2006

    Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)

    Payer SourceTotal Paid
    Medicare$1.3M
    Medicaid$0

    Key Findings

    This provider’s Medicare business is highly concentrated in infused or injected specialty biologic drugs: J0129, J0717, and J3262 together account for 78.0% of the provider’s total Medicare revenue, signaling a practice model built around in-office administration of specialty agents rather than visit-based E/M revenue. The largest single line is J0129 with $698.3K in revenue (51.1% of Medicare revenue), which alone drives more than half of all reported Medicare receipts.

    Overall scale and payer mix: lifetime Medicare revenue is $1.3M while there is no Medicaid billing on file, so the provider operates as effectively single‑payer (Medicare) in the public programs data and would be sensitive to Medicare reimbursement and utilization trends for injectable biologics. The absence of Medicaid claims means any state‑level Medicaid contracting or volume is not reflected in these public records.

    Clinical/service-line implications: the top codes are J‑codes for abatacept (J0129), certolizumab pegol (J0717), and tocilizumab (J3262), with additional J‑codes for golimumab and denosumab and frequent use of infusion/administration codes such as 96365, 96413, and 96415. This mix is characteristic of a rheumatology infusion center or office that bills both the drug and infusion administration, indicating the practice’s revenue is driven by drug administration services and specialty injectable therapies rather than high volumes of E/M office visits.

    Competitive standing by code: J0129 ranks #116 of 1221 providers nationally (91th percentile) and is described as "typical, unremarkable volume for this code," which places the provider toward the upper tier nationally for abatacept revenue while still within typical utilization patterns. By contrast, J0717 (52.4K claims, $209.6K revenue) ranks #382 of 848 (55th percentile) and J3262 ($157.5K revenue) ranks #381 of 618 (38th percentile), indicating more modest or below‑median national positions for these other leading biologic agents.

    Revenue mix vs. visit-based care: E/M codes such as 99214 ($22.3K, 1.6% of Medicare revenue) and 99204 ($9.2K, 0.7%) represent a small share of revenue relative to high-cost J‑codes, underscoring that the business economics are drug-driven rather than encounter-driven. Administrative and infusion/chemotherapy codes (96413, 96365, 96415) appear in the top lines but each contributes a single-digit percentage of revenue, consistent with support services for biologic infusions.

    Laboratory portfolio supports rheumatology practice patterns: multiple immunology and autoimmune serology codes (86235, 86200, 86225, 86226, 86038, 86431) appear among the top 25 Medicare codes, collectively representing routine diagnostic workups commonly associated with rheumatologic care. Each lab line is a small contributor to revenue but together they corroborate a practice focused on autoimmune disease management and monitoring of biologic therapy.

    Tenure and provider stability: the NPI was enumerated on 2006-11-04 (~20 years ago), indicating long-term presence in Medicare billing data which may reflect an established referral base and sustained delivery of infusion-based rheumatology services over time. That long tenure combined with a concentrated drug-revenue profile suggests operational experience in managing biologic therapies within the practice.

    Risk and sensitivity observations: because over three-quarters of Medicare revenue (78.0%) is concentrated in three J‑codes, the provider’s Medicare revenue stream is highly sensitive to changes in reimbursement, utilization policies, or formulary shifts affecting those specific agents. While none of the top J‑codes are flagged as outliers in the plain‑English labels provided (each is characterized as "typical, unremarkable volume for this code"), the economic exposure from heavy dependence on a few specialty drugs is notable for payer negotiations and care‑management planning.

    Medicare: Total Revenue Breakdown by CPT/HCPCS Code

    Medicare revenue breakdown by CPT/HCPCS procedure code.

    View: Bar Chart1 / 2

    Medicare: Complete Services Breakdown

    The CPT/HCPCS codes generating the most Medicare revenue for this provider.

    29 rows

    CPT/HCPCS CodeDescriptionClaimsAvg PaidRevenue
    J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)21,160$30$698.3K
    J0717Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)52,400$1$209.6K
    J3262Injection, tocilizumab, 1 mg31,490$10$157.4K
    J1602Injection, golimumab, 1 mg, for intravenous use14,250$10$156.8K
    J0897Injection, denosumab, 1 mg2,760$20$49.7K
    99214The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…270$80$22.3K
    96413Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…200$90$19K
    96365The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.290$50$13.3K
    99204The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…90$110$9.2K
    86235The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,…380$20$6.4K

    Showing 1–10 of 29

    Medicare: Competitive Analysis & Benchmarks

    How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 29 CPT/HCPCS codes.

    View: State1 / 2

    Full comparison — all codes billed, vs. state median

    29 rows

    CPT/HCPCS CodeRankProvider CountMedian ClaimsAvg PaidAverage Revenue
    J012933010,630$30$391.1K
    J3262111046,210$1$263.4K
    J071762042,400$1$198.8K
    J16026209,500$10$167.1K
    J08971072202,730$20$74.9K
    9641348120140$90$19.1K
    86235310150$20$15.9K
    992142,64810,540110$80$15.5K
    823063911050$30$11.7K
    992139,23310,82080$50$7.6K

    Showing 1–10 of 29

    Related Providers

    Other providers that share a Tax Identification Number (TIN) with Roneka Ravenell, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Community Medical Associates, Inc.KYInternal Medicine Physician$0$135.1M
    Community Medical Associates, Inc.KYMulti-Specialty Clinic/Center$0$49M
    Patricia HansenKYInternal Medicine Physician$2.6M$0
    Timothy LoneskyKYRheumatology Physician$1.5M$0
    Scott LewisKYRheumatology Physician$1.5M$0
    Jennifer TeeterINSports Medicine (Family Medicine) Physician$1.2M$0
    Sarah EstesKYFamily Nurse Practitioner$981.6K$0
    Dana MannKYFamily Nurse Practitioner$824.8K$0
    Melissa ChengKYNurse Practitioner$703.4K$0
    Natasha SmithKYFamily Nurse Practitioner$658K$0

    Nearby Providers

    Other providers in the same ZIP code as Roneka Ravenell, ranked by combined Medicare and Medicaid revenue.

    ProviderStateTaxonomyMedicare RevenueMedicaid Revenue
    Baptist Healthcare System, Inc.INGeneral Acute Care Hospital$0$34.6M
    Nassim And Associates, PscINSpecialist$0$13.8M
    Ohio Valley Medex IncINHome Health Agency$0$13.5M
    Rauch Inc.INEarly Intervention Provider Agency$0$13.3M
    Volunteers Of America Of Kentucky IncINVoluntary or Charitable Agency$0$11.6M
    Physicians Medical Center LLCINGeneral Acute Care Hospital$0$11.4M
    Lifespan ResourcesINCase Management Agency$0$10.7M
    Floyd Emergency Medicine Associates PCINEmergency Medicine Physician$0$6.6M
    Kids Dentistry-new AlbanyINDental Clinic/Center$0$4.6M
    Adaptive Community Support Services IncINDevelopmentally Disabled Services Day Training Agency$0$4.1M

    Frequently Asked Questions

    References

    1. 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
    2. 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Medicare Revenue by CPT/HCPCS Code
    Claims Volume vs. Indiana Distribution
    Roneka Ravenell — 1 of 25 codes billed far more than typical (above p95)
    p5–p95 (all providers)p25–p75MedianThis providerOutlier
    Rank Distribution — Indiana